InVivo Therapeutics Announces Vidant Medical Center as New Site for INSPIRE Study

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) announced that Vidant Medical Center in Greenville, NC has been added as a clinical site for The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury.
According to Mark Perrin, InVivo’s CEO and Chairman:

I am pleased to welcome Dr. Lee and his team to the study and am looking forward to continuing to enroll patients into The INSPIRE Study.

Click here to view the full press release.